How an entwined Bayer and Monsanto could be pruned

Much has already been written about Bayer’s unsolicited bid to take over Monsanto since rumors began to fly on May 12. Articles have discussed the high price Bayer may eventually have to pay, the debt it would have to take on, and the effects on its current stock price. There has also been specul...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Solynta, disruptor in the potato seed industry, raises €21 million to expand true potato seeds (TPS)

News Commentary | July 30, 2021

Solynta, a Netherlands‑based company, raised €21 million in Series C funding to accelerate the full potential of true potato seeds (TPS). Potatoes are predominantly clonally propagated using tubers. Seeds from the potato berries are called true potato seeds. Solynta's innovative F1 hybrid breeding ... Not part of subscription

NuCicer raises USD 4.5 million to commercialize high-protein chickpea variety

News Commentary | March 09, 2022

Plant genetics startup NuCicer announced a USD 4.5 million fundng round led by Lever VC. The University of California – Davis spinout controls significant chickpea genetics and has developed a trait that increases protein content by 75%. The funds will be used for commercialization trials and ... Not part of subscription

Marrone Bio Innovation merging with Bioceres Crop Solutions is an smart strategy for biological product portfolio expansion

Case Study | May 12, 2022

In March 2022, Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that they would merge in an all‑stock transaction. Bioceres also recently acquired Rizobacter, an established biological and chemical solutions platform for crop ... Not part of subscription